218 related articles for article (PubMed ID: 29550947)
1. The Representation of Gender and Race/Ethnic Groups in Randomized Clinical Trials of Individuals with Systemic Lupus Erythematosus.
Falasinnu T; Chaichian Y; Bass MB; Simard JF
Curr Rheumatol Rep; 2018 Mar; 20(4):20. PubMed ID: 29550947
[TBL] [Abstract][Full Text] [Related]
2. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.
Barbhaiya M; Feldman CH; Guan H; Gómez-Puerta JA; Fischer MA; Solomon DH; Everett B; Costenbader KH
Arthritis Rheumatol; 2017 Sep; 69(9):1823-1831. PubMed ID: 28598016
[TBL] [Abstract][Full Text] [Related]
3. Reporting and representation of race/ethnicity in published randomized trials.
Berger JS; Melloni C; Wang TY; Dolor RJ; Frazier CG; Samad Z; Peterson ED; Mark DB; Newby LK
Am Heart J; 2009 Nov; 158(5):742-7. PubMed ID: 19853691
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus.
Barbhaiya M; Feldman CH; Guan H; Chen SK; Fischer MA; Solomon DH; Everett BM; Costenbader KH
Semin Arthritis Rheum; 2019 Apr; 48(5):840-846. PubMed ID: 30205982
[TBL] [Abstract][Full Text] [Related]
5. A comparison of rheumatoid arthritis and systemic lupus erythematosus trial design: a commentary on ways to improve the number of positive trials in SLE.
Miles A; Pope JE
Clin Exp Rheumatol; 2015; 33(5):671-80. PubMed ID: 26315693
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
[TBL] [Abstract][Full Text] [Related]
7. Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review.
Strait A; Castillo F; Choden S; Li J; Whitaker E; Falasinnu T; Schmajuk G; Yazdany J
JAMA Netw Open; 2019 Nov; 2(11):e1914745. PubMed ID: 31722023
[TBL] [Abstract][Full Text] [Related]
8. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
Yuen SY; Pope JE
Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
[TBL] [Abstract][Full Text] [Related]
9. Representation of Race and Ethnicity in Randomized Clinical Trials of Diabetic Macular Edema and Retinal Vein Occlusion Compared to 2010 US Census Data.
Kaakour AH; Hua HU; Rachitskaya A
JAMA Ophthalmol; 2022 Nov; 140(11):1096-1102. PubMed ID: 36201192
[TBL] [Abstract][Full Text] [Related]
10. Representation of women, older patients, ethnic, and racial minorities in trials of atrial fibrillation.
Khan MZ; Munir MB; Khan SU; Subramanian CR; Khan MU; Asad ZUA; Talluri S; Madhanakumar A; Lone AN; Khan MS; Michos ED; Alkhouli M
Pacing Clin Electrophysiol; 2021 Mar; 44(3):423-431. PubMed ID: 33512027
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project.
Maningding E; Dall'Era M; Trupin L; Murphy LB; Yazdany J
Arthritis Care Res (Hoboken); 2020 May; 72(5):622-629. PubMed ID: 31115180
[TBL] [Abstract][Full Text] [Related]
12. Representation of Racial and Ethnic Minorities in Nephrology Clinical Trials: A Systematic Review and Meta-Analysis.
Soomro QH; McCarthy A; Varela D; Keane C; Ways J; Charytan AM; Ramos G; Nicholson J; Charytan DM
J Am Soc Nephrol; 2023 Jul; 34(7):1167-1177. PubMed ID: 37022114
[TBL] [Abstract][Full Text] [Related]
13. Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of systemic lupus erythematosus in Canada: A scoping review.
Thomas M; Verma V; Gheshlaghi N; Esdaile J; Avina-Zubieta A; Barnabe C; Harrison M; De Vera MA
Lupus; 2024 Apr; 33(5):462-469. PubMed ID: 38339797
[TBL] [Abstract][Full Text] [Related]
14. Health disparities in systemic lupus erythematosus-a narrative review.
Hasan B; Fike A; Hasni S
Clin Rheumatol; 2022 Nov; 41(11):3299-3311. PubMed ID: 35907971
[TBL] [Abstract][Full Text] [Related]
15. Representation of adults with rheumatoid arthritis in US-based randomized controlled exercise trials: a systematic review with meta-analysis.
Kelley GA; Kelley KS
Clin Rheumatol; 2023 Jan; 42(1):29-38. PubMed ID: 36152083
[TBL] [Abstract][Full Text] [Related]
16. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus.
Lewis MJ; Jawad AS
Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i67-i77. PubMed ID: 27940583
[TBL] [Abstract][Full Text] [Related]
17. Racial/ethnic diversity in children's oncology clinical trials: ten years later.
Lund MJ; Eliason MT; Haight AE; Ward KC; Young JL; Pentz RD
Cancer; 2009 Aug; 115(16):3808-16. PubMed ID: 19484783
[TBL] [Abstract][Full Text] [Related]
18. Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus - Fulton and DeKalb Counties, Georgia, 2002-2016.
Lim SS; Helmick CG; Bao G; Hootman J; Bayakly R; Gordon C; Drenkard C
MMWR Morb Mortal Wkly Rep; 2019 May; 68(18):419-422. PubMed ID: 31071073
[TBL] [Abstract][Full Text] [Related]
19. Belimumab for systemic lupus erythematosus.
Singh JA; Shah NP; Mudano AS
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010668. PubMed ID: 33631841
[TBL] [Abstract][Full Text] [Related]
20. Increasing Ancestral Diversity in Lupus Trials: Ways Forward.
Falasinnu T; Chaichian Y; Simard JF
Rheum Dis Clin North Am; 2020 Nov; 46(4):713-722. PubMed ID: 32981648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]